57 related articles for article (PubMed ID: 9046328)
1. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors.
Kakeya H; Onozawa C; Sato M; Arai K; Osada H
J Med Chem; 1997 Feb; 40(4):391-4. PubMed ID: 9046328
[No Abstract] [Full Text] [Related]
2. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II.
Mizushina Y; Kobayashi S; Kuramochi K; Nagata S; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2000 Jul; 273(2):784-8. PubMed ID: 10873681
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-inducing effect of epolactaene derivatives on BALL-1 cells.
Kuramochi K; Matsui R; Matsubara Y; Nakai J; Sunoki T; Arai S; Nagata S; Nagahara Y; Mizushina Y; Ikekita M; Kobayashi S
Bioorg Med Chem; 2006 Apr; 14(7):2151-61. PubMed ID: 16298530
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors.
Kuramochi K; Mizushina Y; Nagata S; Sugawara F; Sakaguchi K; Kobayashi S
Bioorg Med Chem; 2004 May; 12(9):1983-9. PubMed ID: 15080901
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.
Nagumo Y; Kakeya H; Yamaguchi J; Uno T; Shoji M; Hayashi Y; Osada H
Bioorg Med Chem Lett; 2004 Sep; 14(17):4425-9. PubMed ID: 15357965
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of epolactaene derivatives as DNA polymerase inhibitors and anti-inflammatory compounds.
Mizushina Y; Kuramochi K; Ikawa H; Kuriyama I; Shimazaki N; Takemura M; Oshige M; Yoshida H; Koiwai O; Sugawara F; Kobayashi S; Sakaguchi K
Int J Mol Med; 2005 May; 15(5):785-93. PubMed ID: 15806299
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and applications of fluorescent and biotinylated epolactaene derivatives: Epolactaene and its derivative induce disulfide formation.
Kuramochi K; Yukizawa S; Ikeda S; Sunoki T; Arai S; Matsui R; Morita A; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2008 May; 16(9):5039-49. PubMed ID: 18375133
[TBL] [Abstract][Full Text] [Related]
8. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus.
Kakeya H; Takahashi I; Okada G; Isono K; Osada H
J Antibiot (Tokyo); 1995 Jul; 48(7):733-5. PubMed ID: 7649877
[No Abstract] [Full Text] [Related]
9. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
10. A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structure.
Nakai J; Kawada K; Nagata S; Kuramochi K; Uchiro H; Kobayashi S; Ikekita M
Biochim Biophys Acta; 2002 Mar; 1581(1-2):1-10. PubMed ID: 11960746
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells.
Olivieri G; Otten U; Meier F; Baysang G; Dimitriades-Schmutz B; Müller-Spahn F; Savaskan E
Neurol Clin Neurophysiol; 2002; 2002(2):2-10. PubMed ID: 12028822
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
13. Effects of NGF on acetylcholine, acetyl-CoA metabolism, and viability of differentiated and non-differentiated cholinergic neuroblastoma cells.
Szutowicz A; Madziar B; Pawełczyk T; Tomaszewicz M; Bielarczyk H
J Neurochem; 2004 Aug; 90(4):952-61. PubMed ID: 15287901
[TBL] [Abstract][Full Text] [Related]
14. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
Chen J; Zhe X
Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
[TBL] [Abstract][Full Text] [Related]
15. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.
Tuffereau C; Bénéjean J; Blondel D; Kieffer B; Flamand A
EMBO J; 1998 Dec; 17(24):7250-9. PubMed ID: 9857182
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells.
Bunone G; Mariotti A; Compagni A; Morandi E; Della Valle G
Oncogene; 1997 Mar; 14(12):1463-70. PubMed ID: 9136990
[TBL] [Abstract][Full Text] [Related]
17. Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.
Nagumo Y; Kakeya H; Shoji M; Hayashi Y; Dohmae N; Osada H
Biochem J; 2005 May; 387(Pt 3):835-40. PubMed ID: 15603555
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
19. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1).
Welker P; Grabbe J; Grützkau A; Henz BM
Immunology; 1998 Jul; 94(3):310-7. PubMed ID: 9771435
[TBL] [Abstract][Full Text] [Related]
20. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
